Binaya Wasti

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Binding Protein

Long Non Coding Rna

Top Venues

Oxidative medicine and cellular longevity

Mediators of inflammation

This page only lists publications with an associated author ORCID identifier.

Publications

Yu Yuan, Yi He, Binaya Wasti, Wentao Duan, Jingsi Jia, Zhifeng Chen, Xu-Dong Xiang, Qingping Zeng
lncRNA CRNDE Affects Th17/IL-17A and Inhibits Epithelial-Mesenchymal Transition in Lung Epithelial Cells Reducing Asthma Signs. Oxidative medicine and cellular longevity 2023 (2023)
Yu Yuan, Yi He, Binaya Wasti, Wentao Duan, Jingsi Jia, Zhifeng Chen, Xu-Dong Xiang, Qingping Zeng
lncRNA CRNDE Affects Th17/IL-17A and Inhibits Epithelial-Mesenchymal Transition in Lung Epithelial Cells Reducing Asthma Signs. Oxidative medicine and cellular longevity 2023 (2023)
Binaya Wasti, Zhifeng Chen, Yu Yuan, Yi He, Wentao Duan, Jingsi Jia, Danhong Li, Bing Xiao, Jianmin Li, Yi Liu, Shao-Kun Liu, Dongshan Zhang, Xiufeng Zhang, Libing Ma, Xu-Dong Xiang
Androgen Plays a Potential Novel Hormonal Therapeutic Role in Th17 Cells Predominant Neutrophilic Severe Asthma by Attenuating BECs Regulated Th17 Cells Differentiation via MBD2 Expression. Oxidative medicine and cellular longevity 2022 (2022)
Binaya Wasti, Zhifeng Chen, Yi He, Wen Tao Duan, Shao-Kun Liu, Xu-Dong Xiang
Role of Sex Hormones at Different Physiobiological Conditions and Therapeutic Potential in MBD2 Mediated Severe Asthma. Oxidative medicine and cellular longevity 2021 (2021)
Binaya Wasti, Shao-Kun Liu, Xu-Dong Xiang
Role of Epigenetics in the Pathogenesis, Treatment, Prediction, and Cellular Transformation of Asthma. Mediators of inflammation 2021 (2021)